跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Dolfenal
Approved
STANDARD
Dolfenal
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
896c200d1ffb6ee3
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
896c200d1ffb6ee3
Drug Approval Philippines Name
Dolfenal
Product Name
Dolfenal
Registration Number
DRP-8778
Brand Name
Dolfenal
Generic Name
Mefenamic Acid
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Amherst Laboratories, Inc.
Issuance Date
24 March 2022
Expiry Date
25 May 2027
Pharmacologic Category
Anti-Inflammatory and Anti-Rheumatic Products, Non-Steroids (Fenamates)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
896c200d1ffb6ee3
Type
Standard
Back to Philippines FDA Approvals
Dolfenal - Philippines FDA Drug Approval Details